Rommel Fernandez Email & Phone Number

Vancouver, B.C., Ca

Cedar Knolls, New Jersey, Us

As Chief Analytics Officer at Fingerpaint Group, I drove organizational change to foster a data-driven culture, leveraging the latest technologies and concepts from generative AI to machine learning models. I led the creation of innovative digital execution strategies, and chaired the data governance committee enhancing organizational processes. My leadership in commercial strategy and advanced analytics played a pivotal role in the success of our healthcare solutions.Key Achievements:• Spearheaded the creation of the Elevalt omnichannel solution, achieving >40% efficiency gains with innovative digital strategies for healthcare stakeholders.• Drove data and analytics transformation, resulting in a [specific measurable outcome, e.g., a 30% increase in data-driven decision-making across healthcare services].• Chaired the data governance committee, achieving 100% compliance through comprehensive process enhancements and framework implementation.

At 1798 Consulting, I played a pivotal role in providing strategic healthcare consulting services, focusing on market access strategies and value proposition development. As a member of the Executive Committee, I contributed to shaping both short-term and long-term organizational plans. My expertise in commercial strategy and financial modeling was instrumental in driving high-impact client engagements across various healthcare sectors.Key Achievements:• Led strategic portfolio engagements for a Biosimilar Oncology market with an annual spend of $34B, resulting in optimized contracting designs.• Developed and implemented financial models to drive market access strategies, leading to improved Gross2Net and patient support models.• Spearheaded multiple client engagements, delivering actionable insights that resulted in faster decision making and increased net revenue.

As the founder and principal of Matalino LLC, I established a strategic biotech advisory firm dedicated to providing expert commercialization support across the product lifecycle. My work focused on market research, strategic planning, and financial forecasting, enabling early-stage biotechnology companies to secure funding and drive growth.Key Achievements:• Executed comprehensive market research and forecasting models, successfully supporting a Series B funding round for a discovery-phase biotechnology company.• Provided expert advisory services that helped early-stage biotech firms navigate complex regulatory landscapes and optimize their commercialization strategies.

Waltham, Ma, Us

At La Jolla Pharmaceutical, I held a senior leadership role where I guided the organization from pre-commercial stages to full commercial build-out and market launch. My role was pivotal in achieving substantial market penetration and financial success for GIAPREZA in the hospital market through data-driven strategies and insights.Key Achievements:• Increased hospital reimbursements by up to 50% for Medicare patients by securing the Center for Medicaid and Medicare Services New Technology Add-On Payment (NTAP) designation.• Achieved GIAPREZA formulary approvals in over 300 institutions, resulting in over $10 million in sales within the launch year, leveraging key market insights and analytics-based targeting.• Drove commercial and market access strategy development, ensuring optimal product positioning and market uptake.

La Jolla, Ca, Us

Directed global commercial planning and strategizing for launch and commercialization of healthcare provider and patient-centric markets. Delivered broad organizational decision support with intricate market research, patient analysis, and global sourcing.• Guided significant investment in Direct to Consumer (DTC) advertising with oversight of health care and patient market research team.• Facilitated $1M in market research branding and promoting new research, products, and services with cross-functional integration campaigns.• Led development of key investor relations metrics and materials that were integral to securing significant investment funding for the US Contrave relaunch.

Dublin, Ireland, Ie

Drove cross-functional teams through analysis, forecasting, and market research focused on increasing commercial impacts. Tracked spending, developed and presented reports to corporate-level executives, and led cross-functional teams to exceed organizational goals.• Led integration work streams during the Mallinckrodt $1.4B acquisition of Cadence.• Instrumental to eight-month implementation of Sunshine Act reporting program expediting reporting for critical go-live timeframe of the law by tracking spend tied to health care providers.

San Diego, Ca, Us

Orchestrated commercial business unit modeling and analysis for executive leadership to provide advisement on sales force and investment decisions. Successfully negotiated contract terms, tracked spending, and devised portfolio model management. Optimized commercial CRM analytics and customer data integration. Focused on KPIs during development of commercial capabilities taking into consideration utilization, measurement, and execution for sales force, managed markets, and field medical terms.• Achieved over $800M in yearly revenues with initiation of multiple sale force models for a diabetes portfolio.• Effectively mediated dissolution of Eli Lilly partnership transferring control of Exenatide franchise with a transaction value of $1.6B.• Coordinated alliance execution covering more than 400 FTEs for the promotion of a diabetes portfolio.

Paris, Fr

Global consulting group with focus on strategy and system integration to deliver high-value initiatives on time and within budget.

Bachelors Of Science (B.S.), Business Administration (Information Decision Systems)

Associates Science, General Education